UKHSA Releases Monthly Hospital Infection Data for 2025–26

The UK Health Security Agency (UKHSA) has published a new set of accredited official statistics monitoring healthcare-associated infections in England. The release covers the 2025 to 2026 period and is updated monthly, providing a rolling picture of infection trends across NHS organisations.

What the Data Covers

The publication tracks four categories of infection: meticillin-resistant Staphylococcus aureus (MRSA), meticillin-sensitive Staphylococcus aureus (MSSA), Gram-negative bacteraemia, and Clostridioides difficile infections (CDI). Each category is reported with a level of granularity intended to support surveillance efforts at the organisational level.

For MRSA, MSSA, and Gram-negative bacteraemia, the statistics are broken down both by NHS organisation and by the location where the infection is believed to have originated. This distinction between community-onset and hospital-onset cases is a standard feature of infection surveillance, allowing public health bodies to assess where transmission may be occurring.

How CDI Data Is Reported

The Clostridioides difficile figures follow a slightly different structure. Rather than an onset-location breakdown, CDI data is disaggregated by organisation and by prior trust exposure — a classification that reflects whether a patient had recent contact with a healthcare setting before the infection was identified. This framing helps distinguish cases that may be linked to healthcare environments from those arising in the wider community.

The Role of Monthly Surveillance

Monthly reporting of this kind forms part of the broader infrastructure for monitoring antimicrobial resistance and hospital-acquired infection trends in England. By publishing data at the NHS organisation level, the UKHSA release allows for comparisons across trusts and over time, supporting accountability and ongoing public health monitoring.

The full dataset is available via the UKHSA official statistics page, where monthly updates are added as they become available throughout the 2025 to 2026 period.